Registro:

Referencias:

• Sowell, M.O., Mukhopadhyay, N., Cavazzoni, P., Shankar, S., Steinberg, H.O., Breier, A., Beasley Jr., C.M., Dananberg, J., Hyperglycemic clamp assessment of insulin secretory responses in normal subjects treated with olanzapine, risperidone, or placebo (2002) J Clin Endocrinol Metab, 87, pp. 2918-2923
• Pijl, H., Reduced dopaminergic tone in hypothalamic neural circuits: Expression of a "thrifty" genotype underlying the metabolic syndrome? (2003) Eur J Pharmacol, 480, pp. 125-131
• Citrome, L., Jaffe, A., Levine, J., Allingham, B., Robinson, J., Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients (2004) Psychiatr Serv, 55, pp. 1006-1013
• Marder, S.R., Essock, S.M., Miller, A.L., Buchanan, R.W., Casey, D.E., Davis, J.M., Kane, J.M., Shon, S., Physical health monitoring of patients with schizophrenia (2004) Am J Psychiatry, 161, pp. 1334-1349
• Lebovitz, H.E., Metabolic consequences of atypical antipsychotic drugs (2003) Psychiatr Q, 74, pp. 277-290
• Rosati, G., Maioli, M., Aiello, I., Farris, A., Agnetti, V., Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson's disease (1976) Eur Neurol, 14, pp. 229-239
• Ericson, L.E., Håkanson, R., Lundquist, I., Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion (1977) Diabetologia, 13, pp. 117-124
• Zern, R.T., Bird, J.L., Feldman, J.M., Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster (1980) Diabetologia, 18, pp. 341-346
• Baptista, T., Lacruz, A., Pàez, X., Hernández, L., Beaulieu, S., The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved? (2002) Eur J Pharmacol, 447, pp. 91-98
• Ahrén, B., Autonomic regulation of islet hormone secretion-implications for health and disease (2000) Diabetologia, 43, pp. 393-410
• Missale, C., Nash, S.R., Robinson, S.W., Jaber, M., Caron, M.G., Dopamine receptors: From structure to function (1998) Physiol Rev, 78, pp. 189-225
• Nogueira, C.R., Machado, U.F., Curi, R., Carpinelli, A.R., Modulation of insulin secretion and45Ca2+ efflux by dopamine in glucose-stimulated pancreatic islets (1994) Gen Pharmacol, 25, pp. 909-916
• Rubí, B., Ljubicic, S., Pournourmohammadi, S., Carobbio, S., Armanet, M., Bartley, C., Maechler, P., Dopamine D2-like receptors are expressed in pancreatic β-cells and mediate inhibition of insulin secretion (2005) J Biol Chem, 280, pp. 36824-36832
• Shankar, E., Santhosh, K.T., Paulose, C.S., Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro (2006) IUBMB Life, 58, pp. 157-163
• Asa, S.L., Kelly, M.A., Grandy, D.K., Low, M.J., Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice (1999) Endocrinology, 140, pp. 5348-5355
• Kelly, M.A., Rubinstein, M., Asa, S.L., Zhang, G., Saez, C., Bunzow, J.R., Allen, R.G., Low, M.J., Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice (1997) Neuron, 19, pp. 103-113
• Díaz-Torga, G., Feierstein, C., Libertun, C., Gelman, D., Kelly, M.A., Low, M.J., Rubinstein, M., Becú-Villalobos, D., Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice (2002) Endocrinology, 143, pp. 1270-1279
• García-Tornadú, I., Rubinstein, M., Gaylinn, B.D., Hill, D., Arany, E., Low, M.J., Díaz-Torga, G., Becu-Villalobos, D., GH in the dwarf dopaminergic D2 receptor knockout mouse: Somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin (2006) J Endocrinol, 190, pp. 611-619
• Gong, S., Zheng, C., Doughty, M.L., Losos, K., Didkovsky, N., Schambra, U.B., Nowak, N.J., Heintz, N., A gene expression atlas of the central nervous system based on bacterial artificial chromosomes (2003) Nature, 425, pp. 917-925
• Kelly, M.A., Rubinstein, M., Phillips, T.J., Lessov, C.N., Burkhart-Kasch, S., Zhang, G., Bunzow, J.R., Low, M.J., Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations (1998) J Neurosci, 18, pp. 3470-3479
• Cristina, C., Díaz-Torga, G., Baldi, A., Góngora, A., Rubinstein, M., Low, M.J., Becú-Villalobos, D., Increased pituitary vascular endothelial growth factor-A in dopaminergic D2 receptor knockout female mice (2005) Endocrinology, 146, pp. 2952-2962
• Xu, R., Parlow, A.F., Wang, Y., The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor (2002) Brain Res, 939, pp. 95-99
• Joseph, J.W., Koshkin, V., Saleh, M.C., Sivitz, W.I., Zhang, C.Y., Lowell, B.B., Chan, C.B., Wheeler, M.B., Free fatty acid-induced β-cell defects are dependent on uncoupling protein 2 expression (2004) J Biol Chem, 279, pp. 51049-51056
• Lacau-Mengido, I.M., Mejía, M.E., Díaz-Torga, G.S., Gonzalez Iglesias, A., Formía, N., Libertun, C., Becú-Villalobos, D., Endocrine studies in ivermectin-treated heifers from birth to puberty (2000) J Anim Sci, 78, pp. 817-824
• Díaz-Torga, G.S., Mejia, M.E., González-Iglesias, A., Formia, N., Becú-Villalobos, D., Lacau-Mengido, I.M., Metabolic cues for puberty onset in free grazing Holstein heifers naturally infected with nematodes (2001) Theriogenology, 56, pp. 111-122
• Petrik, J., Arany, E., McDonald, T.J., Hill, D.J., Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor (1998) Endocrinology, 139, pp. 2994-3004
• Chamson-Reig, A., Thyssen, S.M., Hill, D.J., Arany, E., Exposure of the pregnant rat to low protein diet causes impaired glucose homeostasis in the young adult offspring by different mechanisms in males and females (2009) Exp Biol Med, 234, pp. 1425-1436. , Maywood
• Blaak, E., Sex differences in the control of glucose homeostasis (2008) Curr Opin Clin Nutr Metab Care, 11, pp. 500-504
• Arneriæ, S.P., Chow, S.A., Long, J.P., Fischer, L.J., Inhibition of insulin release from rat pancreatic islets by drugs that are analogues of dopamine (1984) Diabetes, 33, pp. 888-893
• Shankar, P.N., Joseph, A., Paulose, C.S., Decreased [3H] YM-09151-2 binding to dopamine D2 receptors in the hypothalamus, brainstem and pancreatic islets of streptozotocin-induced diabetic rats (2007) Eur J Pharmacol, 557, pp. 99-105
• Ahrén, B., Lundquist, I., Effects of L-dopa-induced dopamine accumulation on45Ca 2+ efflux and insulin secretion in isolated rat islets (1985) Pharmacology, 30, pp. 71-82
• Nussey, S.S., Whitehead, S.A., The endocrine pancreas (2001) Endocrinology: An Integrated Approach, pp. 23-68. , Oxford, UK: BIOS Scientific Publishers
• Lang, J., Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion (1999) Eur J Biochem, 259, pp. 3-17
• Sorenson, R.L., Brelje, T.C., Adaptation of islets of Langerhans to pregnancy: β-cell growth, enhanced insulin secretion and the role of lactogenic hormones (1997) Horm Metab Res, 29, pp. 301-307
• Brelje, T.C., Scharp, D.W., Lacy, P.E., Ogren, L., Talamantes, F., Robertson, M., Friesen, H.G., Sorenson, R.L., Effect of homologous placental lactogens, prolactins, and growth hormones on islet B-cell division and insulin secretion in rat, mouse, and human islets: Implication for placental lactogen regulation of islet function during pregnancy (1993) Endocrinology, 132, pp. 879-887
• Sorenson, R.L., Brelje, T.C., Roth, C., Effects of steroid and lactogenic hormones on islets of Langerhans: A new hypothesis for the role of pregnancy steroids in the adaptation of islets to pregnancy (1993) Endocrinology, 133, pp. 2227-2234
• Petryk, A., Fleenor, D., Driscoll, P., Freemark, M., Prolactin induction of insulin gene expression: The roles of glucose and glucose transporter-2 (2000) J Endocrinol, 164, pp. 277-286
• Fleenor, D.E., Freemark, M., Prolactin induction of insulin gene transcription: Roles of glucose and signal transducer and activator of transcription 5 (2001) Endocrinology, 142, pp. 2805-2810
• Kim, S.Y., Sung, Y.A., Ko, K.S., Cho, B.Y., Lee, H.K., Koh, C.S., Min, H.K., Direct relationship between elevated free testosterone and insulin resistance in hyperprolactinemic women (1993) Korean J Intern Med, 8, pp. 8-14
• Pelkonen, R., Nikkila, E.A., Grahne, B., Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma (1982) Clin Endocrinol, 16, pp. 383-390. , Oxf
• Foss, M.C., Paula, F.J., Paccola, G.M., Piccinato, C.E., Peripheral glucose metabolism in human hyperprolactinaemia (1995) Clin Endocrinol, 43, pp. 721-726. , Oxf
• Freemark, M., Avril, I., Fleenor, D., Driscoll, P., Petro, A., Opara, E., Kendall, W., Kelly, P.A., Targeted deletion of the PRL receptor: Effects on islet development, insulin production, and glucose tolerance (2002) Endocrinology, 143, pp. 1378-1385
• Nielsen, J.H., Linde, S., Welinder, B.S., Billestrup, N., Madsen, O.D., Growth hormone is a growth factor for the differentiated pancreatic β-cell (1989) Mol Endocrinol, 3, pp. 165-173
• Hügl, S.R., White, M.F., Rhodes, C.J., Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells (1998) J Biol Chem, 273, pp. 17771-17779
• Harrison, M., Dunger, A.M., Berg, S., Mabley, J., John, N., Green, M.H., Green, I.C., Growth factor protection against cytokine-induced apoptosis in neonatal rat islets of Langerhans: Role of Fas (1998) FEBS Lett, 435, pp. 207-210
• Guo, Y., Lu, Y., Houle, D., Robertson, K., Tang, Z., Kopchick, J.J., Liu, Y.L., Liu, J.L., Pancreatic islet-specific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice (2005) Endocrinology, 146, pp. 2602-2609
• Dominici, F.P., Hauck, S., Argentino, D.P., Bartke, A., Turyn, D., Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice (2002) J Endocrinol, 173, pp. 81-94
• Wolfsdorf, J.I., Sadeghi-Nejad, A., Senior, B., Hypoketonemia and age-related fasting hypoglycemia in growth hormone deficiency (1983) Metabolism, 32, pp. 457-462
• Merimee, T.J., Felig, P., Marliss, E., Fineberg, S.E., Cahill Jr., G.G., Glucose and lipid homeostasis in the absence of human growth hormone (1971) J Clin Invest, 50, pp. 574-582
• Cuneo, R.C., Salomon, F., Mc Gauley, G.A., Sonksen, P.H., The growth hormone deficiency syndrome in adults (1992) Clin Endocrinol, 37, pp. 387-397. , Oxf
• Jørgensen, J.O., Vestergaard, E., Gormsen, L., Jessen, N., Nørrelund, H., Christiansen, J.S., Møller, N., Metabolic consequences of GH deficiency (2005) J Endocrinol Invest, 28, pp. 47-51
• Pijl, H., Ohashi, S., Matsuda, M., Miyazaki, Y., Mahankali, A., Kumar, V., Pipek, R., De Fronzo, R.A., Bromocriptine: A novel approach to the treatment of type 2 diabetes (2000) Diabetes Care, 23, pp. 1154-1161
• Luo, S., Luo, J., Meier, A.H., Cincotta, A.H., Dopaminergic neurotoxin administration to the area of the suprachiasmatic nuclei induces insulin resistance (1997) Neuroreport, 8, pp. 3495-3499
• Noain, D., Gelman, D., Bello-Gay, E., Pepper, M., Garcia-Tornadu, I., Becu-Villalobos, D., Low, M.J., Rubinstein, M., Neuronal dopamine D2 receptors promote aggressive and territorial behaviors between male mice Scientific Sessions of the 39th Annual Meeting of the Society for Neuroscience, Chicago, IL, 2009, p. 65. , (Abstract 377.10/FF69) Book 4
• Amiel, J.M., Mangurian, C.V., Ganguli, R., Newcomer, J.W., Addressing cardiometabolic risk during treatment with antipsychotic medications (2008) Curr Opin Psychiatry, 21, pp. 613-618
• Newcomer, J.W., Haupt, D.W., Fucetola, R., Melson, A.K., Schweiger, J.A., Cooper, B.P., Selke, G., Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia (2002) Arch Gen Psychiatry, 59, pp. 337-345
• Haupt, D.W., Newcomer, J.W., Hyperglycemia and antipsychotic medications (2001) J Clin Psychiatry, 62 (SUPPL. 27), pp. 15-26
• Chintoh, A.F., Mann, S.W., Lam, L., Giacca, A., Fletcher, P., Nobrega, J., Remington, G., Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model (2009) Schizophr Res, 108, pp. 127-133
• Lipscombe, L.L., Lévesque, L., Gruneir, A., Fischer, H.D., Juurlink, D.N., Gill, S.S., Herrmann, N., Rochon, P.A., Antipsychotic drugs and hyperglycemia in older patients with diabetes (2009) Arch Intern Med, 169, pp. 1282-1289

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------